+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Preclinical Isolated Organ Perfusion System Market 2024-2028

  • PDF Icon

    Report

  • 156 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 5188693
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preclinical isolated organ perfusion system market is forecasted to grow by USD 137.63 mn during 2023-2028, accelerating at a CAGR of 4.86% during the forecast period. The report on the preclinical isolated organ perfusion system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, growing demand for organ transplantation, and rising awareness about isolated organ research.

The preclinical isolated organ perfusion system market is segmented as below:

By End-user

  • Industrial laboratories and CROs
  • Academic and government research institutes

By Type

  • Isolated heart perfusion systems
  • Isolated abdominal organ perfusion systems
  • Isolated lung perfusion systems
  • Cell isolation and others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rise in preclinical research and testing on various diseases as one of the prime reasons driving the preclinical isolated organ perfusion system market growth during the next few years. Also, technological advances related to isolated organ perfusion systems and increasing investment in R and D and preclinical research will lead to sizable demand in the market.

The report on the preclinical isolated organ perfusion system market covers the following areas:

  • Preclinical isolated organ perfusion system market sizing
  • Preclinical isolated organ perfusion system market forecast
  • Preclinical isolated organ perfusion system market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical isolated organ perfusion system market vendors that include ADInstruments Pty Ltd., ALA Scientific Instruments Inc., emka TECHNOLOGIES, Harvard Bioscience Inc., MDE GmbH, Radnoti LLC, World Precision Instruments, and XVIVO Perfusion AB. Also, the preclinical isolated organ perfusion system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global preclinical isolated organ perfusion system market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global preclinical isolated organ perfusion system market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Industrial laboratories and CROs - Market size and forecast 2023-2028
Exhibit 34: Chart on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
6.4 Academic and government research institutes - Market size and forecast 2023-2028
Exhibit 38: Chart on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ million)
Exhibit 43: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 44: Chart on Type - Market share 2023-2028 (%)
Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Isolated heart perfusion systems - Market size and forecast 2023-2028
Exhibit 48: Chart on Isolated heart perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Isolated heart perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Isolated heart perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Isolated heart perfusion systems - Year-over-year growth 2023-2028 (%)
7.4 Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028
Exhibit 52: Chart on Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Isolated abdominal organ perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Isolated abdominal organ perfusion systems - Year-over-year growth 2023-2028 (%)
7.5 Isolated lung perfusion systems - Market size and forecast 2023-2028
Exhibit 56: Chart on Isolated lung perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Isolated lung perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Isolated lung perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Isolated lung perfusion systems - Year-over-year growth 2023-2028 (%)
7.6 Cell isolation and others - Market size and forecast 2023-2028
Exhibit 60: Chart on Cell isolation and others - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Cell isolation and others - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Cell isolation and others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Cell isolation and others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 ADInstruments Pty Ltd.
Exhibit 115: ADInstruments Pty Ltd. - Overview
Exhibit 116: ADInstruments Pty Ltd. - Product/Service
Exhibit 117: ADInstruments Pty Ltd. - Key offerings
12.4 ALA Scientific Instruments Inc.
Exhibit 118: ALA Scientific Instruments Inc. - Overview
Exhibit 119: ALA Scientific Instruments Inc. - Product/Service
Exhibit 120: ALA Scientific Instruments Inc. - Key offerings
12.5 emka TECHNOLOGIES
Exhibit 121: emka TECHNOLOGIES - Overview
Exhibit 122: emka TECHNOLOGIES - Product/Service
Exhibit 123: emka TECHNOLOGIES - Key offerings
12.6 Harvard Bioscience Inc.
Exhibit 124: Harvard Bioscience Inc. - Overview
Exhibit 125: Harvard Bioscience Inc. - Product/Service
Exhibit 126: Harvard Bioscience Inc. - Key offerings
12.7 MDE GmbH
Exhibit 127: MDE GmbH - Overview
Exhibit 128: MDE GmbH - Product/Service
Exhibit 129: MDE GmbH - Key offerings
12.8 Radnoti LLC
Exhibit 130: Radnoti LLC - Overview
Exhibit 131: Radnoti LLC - Product/Service
Exhibit 132: Radnoti LLC - Key offerings
12.9 World Precision Instruments
Exhibit 133: World Precision Instruments - Overview
Exhibit 134: World Precision Instruments - Product/Service
Exhibit 135: World Precision Instruments - Key offerings
12.10 XVIVO Perfusion AB
Exhibit 136: XVIVO Perfusion AB - Overview
Exhibit 137: XVIVO Perfusion AB - Business segments
Exhibit 138: XVIVO Perfusion AB - Key offerings
Exhibit 139: XVIVO Perfusion AB - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 140: Inclusions checklist
Exhibit 141: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 142: Currency conversion rates for US$
13.4 Research methodology
Exhibit 143: Research methodology
Exhibit 144: Validation techniques employed for market sizing
Exhibit 145: Information sources
13.5 List of abbreviations
Exhibit 146: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global preclinical isolated organ perfusion system market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by End-user ($ million)
Exhibits 43: Data Table on Market opportunity by End-user ($ million)
Exhibits 44: Chart on Type - Market share 2023-2028 (%)
Exhibits 45: Data Table on Type - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Type
Exhibits 47: Data Table on Comparison by Type
Exhibits 48: Chart on Isolated heart perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Isolated heart perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Isolated heart perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Isolated heart perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Isolated abdominal organ perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Isolated abdominal organ perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Isolated lung perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Isolated lung perfusion systems - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Isolated lung perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Isolated lung perfusion systems - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Cell isolation and others - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Cell isolation and others - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Cell isolation and others - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Cell isolation and others - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by Type ($ million)
Exhibits 65: Data Table on Market opportunity by Type ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: ADInstruments Pty Ltd. - Overview
Exhibits 116: ADInstruments Pty Ltd. - Product/Service
Exhibits 117: ADInstruments Pty Ltd. - Key offerings
Exhibits 118: ALA Scientific Instruments Inc. - Overview
Exhibits 119: ALA Scientific Instruments Inc. - Product/Service
Exhibits 120: ALA Scientific Instruments Inc. - Key offerings
Exhibits 121: emka TECHNOLOGIES - Overview
Exhibits 122: emka TECHNOLOGIES - Product/Service
Exhibits 123: emka TECHNOLOGIES - Key offerings
Exhibits 124: Harvard Bioscience Inc. - Overview
Exhibits 125: Harvard Bioscience Inc. - Product/Service
Exhibits 126: Harvard Bioscience Inc. - Key offerings
Exhibits 127: MDE GmbH - Overview
Exhibits 128: MDE GmbH - Product/Service
Exhibits 129: MDE GmbH - Key offerings
Exhibits 130: Radnoti LLC - Overview
Exhibits 131: Radnoti LLC - Product/Service
Exhibits 132: Radnoti LLC - Key offerings
Exhibits 133: World Precision Instruments - Overview
Exhibits 134: World Precision Instruments - Product/Service
Exhibits 135: World Precision Instruments - Key offerings
Exhibits 136: XVIVO Perfusion AB - Overview
Exhibits 137: XVIVO Perfusion AB - Business segments
Exhibits 138: XVIVO Perfusion AB - Key offerings
Exhibits 139: XVIVO Perfusion AB - Segment focus
Exhibits 140: Inclusions checklist
Exhibits 141: Exclusions checklist
Exhibits 142: Currency conversion rates for US$
Exhibits 143: Research methodology
Exhibits 144: Validation techniques employed for market sizing
Exhibits 145: Information sources
Exhibits 146: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global preclinical isolated organ perfusion system market: ADInstruments Pty Ltd., ALA Scientific Instruments Inc., emka TECHNOLOGIES, Harvard Bioscience Inc., MDE GmbH, Radnoti LLC, World Precision Instruments, and XVIVO Perfusion AB.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rise in preclinical research and testing on various diseases.'

According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ADInstruments Pty Ltd.
  • ALA Scientific Instruments Inc.
  • emka TECHNOLOGIES
  • Harvard Bioscience Inc.
  • MDE GmbH
  • Radnoti LLC
  • World Precision Instruments
  • XVIVO Perfusion AB